Cancer Treatment Treatment Breast Cancer Chemotherapy Cancer Diagnosis Immunotherapy Prostate Cancer Brain Cancer Preventative Chemotherapy Diagnosis Cancer Research Types of Cancer Pancreatic Cancer Melanoma Liver Cancer Research Tumor Microenvironment Survival Rates Glioblastoma Metastatic Cancer Clinical trials Cancer Vaccines Cancer Immunotherapy Terminal Illness Clinical Trials Patient Outcomes Patient Experience Tumor Heterogeneity Treatment Options Royal Family Preventative Measures Vascular Health Tumour Characteristics Leukaemia Bowel Cancer Surgery Abdominal Cancer Therapeutic Cancer Vaccines Squamous Cell Carcinoma Types Colon cancer Obesity-Associated Cancers Bone Cancer Type of Cancer Cancer History Leukemia Princess of Wales Cancer Cachexia Non-Hodgkin’s Lymphoma Cancer Statistics Treatment Side Effects Radioconjugates Lymphoma Lung Cancer Royal Health Issues Brain Tumors Blood Cancer Immunology Experimental Treatments Princess Catherine Preventive Chemotherapy Cancer Immunology Cancer Therapy Bone Metastases Stages of Cancer Laryngeal Cancer Skin Cancer Public Figures' Health Battles Risk Factors Ovarian Cancer Metastatic tumors Health Disparities Cell Biology Therapeutics Aging Invasive Cribriform Carcinoma Talc Diagnosis and Treatment Cancer Types Precision Medicine mRNA technology Environmental Factors Vaccines Cancer Biology Gene Therapy Personalized Therapy Prognosis Factors Multiple Myeloma Cancer Treatment Advancements Colon Cancer Young adult cancer cases Immune System Stimulation Testicular Cancer Thyroid Cancer Sarcoma Bone Issues
Releasing three synergistic drugs directly at tumor sites, the implant bypasses the blood‑brain barrier and points to a path for clinical translation.
